IKT

Inhibikase Therapeutics, Inc.$2.06+0.01 (+0.24%)

Prev Close$2.06·MCap$270.7M·P/E—·Vol803.8K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$0.00

●

Active Insiders

last 12 mo

IKT Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 23, 2024	Bellini Roberto		Buy	1,460,000	$1.37	$2.00M2.1% OS	1,460,000
Oct 23, 2024	Kush Arvind		Buy	145,000	$1.37	$198.7K	145,000
Oct 23, 2024	Munshi Amit		Buy	365,000	$1.37	$500.1K0.5% OS	365,000
Aug 16, 2022	Werner Milton H.	President and CEO	Buy	5,000	$0.80	$4.0K	5,335,433
May 31, 2022	Werner Milton H.	President and CEO	Buy	5,000	$0.98	$4.9K	5,330,433
May 23, 2022	FRATTAROLI JOSEPH	Chief Financial Officer	Buy	3,948	$0.64	$2.5K	48,091
May 23, 2022	Werner Milton H.	President and CEO	Buy	10,000	$0.60	$6.0K	5,325,433
Nov 19, 2021	Werner Milton H.	President and CEO	Buy	23,589	$1.97	$46.6K	23,589

The following table shows recent insider purchases of Inhibikase Therapeutics, Inc. (IKT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 23, 2024	Bellini Roberto		Buy	1,460,000	$1.37	$2.00M2.1% OS	1,460,000
Oct 23, 2024	Kush Arvind		Buy	145,000	$1.37	$198.7K	145,000
Oct 23, 2024	Munshi Amit		Buy	365,000	$1.37	$500.1K0.5% OS	365,000
Aug 16, 2022	Werner Milton H.	President and CEO	Buy	5,000	$0.80	$4.0K	5,335,433
May 31, 2022	Werner Milton H.	President and CEO	Buy	5,000	$0.98	$4.9K	5,330,433
May 23, 2022	FRATTAROLI JOSEPH	Chief Financial Officer	Buy	3,948	$0.64	$2.5K	48,091
May 23, 2022	Werner Milton H.	President and CEO	Buy	10,000	$0.60	$6.0K	5,325,433
Nov 19, 2021	Werner Milton H.	President and CEO	Buy	23,589	$1.97	$46.6K	23,589